Monoclonal antibody 13F1 produces annular immunofluorescence patterns on Cryptococcus neoformans serotype AD isolates.
作者信息
Cleare W, Brandt M E, Casadevall A
出版信息
J Clin Microbiol. 1999 Sep;37(9):3080. doi: 10.1128/JCM.37.9.3080-3080.1999.
Abstract
摘要
相似文献
1
Monoclonal antibody 13F1 produces annular immunofluorescence patterns on Cryptococcus neoformans serotype AD isolates.
J Clin Microbiol. 1999 Sep;37(9):3080. doi: 10.1128/JCM.37.9.3080-3080.1999.
2
The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays.
Clin Diagn Lab Immunol. 1998 Mar;5(2):125-9. doi: 10.1128/CDLI.5.2.125-129.1998.
3
Prevalence in Cryptococcus neoformans strains of a polysaccharide epitope which can elicit protective antibodies.
Clin Diagn Lab Immunol. 1994 Nov;1(6):737-40. doi: 10.1128/cdli.1.6.737-740.1994.
4
Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy.
J Exp Med. 1997 Feb 17;185(4):685-94. doi: 10.1084/jem.185.4.685.
5
Molecular basis for immunoglobulin M specificity to epitopes in Cryptococcus neoformans polysaccharide that elicit protective and nonprotective antibodies.
Infect Immun. 2001 May;69(5):3398-409. doi: 10.1128/IAI.69.5.3398-3409.2001.
6
Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.
Infect Immun. 2004 Aug;72(8):4810-8. doi: 10.1128/IAI.72.8.4810-4818.2004.
7
Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide.
Infect Immun. 1989 Oct;57(10):3240-2. doi: 10.1128/iai.57.10.3240-3242.1989.
8
Serotyping Cryptococcus neoformans by immunofluorescence.
J Clin Microbiol. 1981 Sep;14(3):313-7. doi: 10.1128/jcm.14.3.313-317.1981.
9
Murine monoclonal antibodies recognizing a non-capsular antigen that distinguishes between Cryptococcus neoformans var. neoformans and C. neoformans var. gattii.
Trans R Soc Trop Med Hyg. 1991 Jan-Feb;85(1):123-7. doi: 10.1016/0035-9203(91)90184-z.
10
引用本文的文献
1
Glycans From Distinct Genotypes Share Structural and Serological Similarities to Glucuronoxylomannan.
Front Cell Infect Microbiol. 2021 Jan 8;10:565571. doi: 10.3389/fcimb.2020.565571. eCollection 2020.
2
Antibody binding to Cryptococcus neoformans impairs budding by altering capsular mechanical properties.
J Immunol. 2013 Jan 1;190(1):317-23. doi: 10.4049/jimmunol.1202324. Epub 2012 Dec 10.
3
The capsule of the fungal pathogen Cryptococcus neoformans.
Adv Appl Microbiol. 2009;68:133-216. doi: 10.1016/S0065-2164(09)01204-0.
4
Molecular basis for immunoglobulin M specificity to epitopes in Cryptococcus neoformans polysaccharide that elicit protective and nonprotective antibodies.
Infect Immun. 2001 May;69(5):3398-409. doi: 10.1128/IAI.69.5.3398-3409.2001.
5
Antibody interactions with the capsule of Cryptococcus neoformans.
Infect Immun. 2000 Jun;68(6):3642-50. doi: 10.1128/IAI.68.6.3642-3650.2000.
本文引用的文献
1
Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates.
J Clin Microbiol. 1999 Mar;37(3):838-40. doi: 10.1128/JCM.37.3.838-840.1999.
2
The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays.
Clin Diagn Lab Immunol. 1998 Mar;5(2):125-9. doi: 10.1128/CDLI.5.2.125-129.1998.
3
Identification by polymerase chain reaction fingerprinting of Cryptococcus neoformans serotype AD.
J Med Vet Mycol. 1997 Sep-Oct;35(5):355-60.
4
Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy.
J Exp Med. 1997 Feb 17;185(4):685-94. doi: 10.1084/jem.185.4.685.
5
Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group.
J Clin Microbiol. 1996 Apr;34(4):912-7. doi: 10.1128/jcm.34.4.912-917.1996.
6
Production of agglutinating monoclonal antibody against antigen 8 specific for Cryptococcus neoformans serotype D.
Clin Diagn Lab Immunol. 1996 Jan;3(1):89-92. doi: 10.1128/cdli.3.1.89-92.1996.
7
Epidemiology studies of clinical isolates of Cryptococcus neoformans of Japan by restriction fragment length polymorphism.
Kansenshogaku Zasshi. 1994 Dec;68(12):1512-7. doi: 10.11150/kansenshogakuzasshi1970.68.1512.
8
Comparison of multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for molecular subtyping of Cryptococcus neoformans. The Cryplococcal Disease Active Surveillance Group.
J Clin Microbiol. 1995 Jul;33(7):1890-5. doi: 10.1128/jcm.33.7.1890-1895.1995.
9
Comparison of serological and chemical characteristics of capsular polysaccharides of Cryptococcus neoformans var. neoformans serotype A and Cryptococcus albidus var. albidus.
Microbiol Immunol. 1991;35(2):125-38. doi: 10.1111/j.1348-0421.1991.tb01540.x.
Zotero 插件